Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
...sometimes wolves in sheeps clothing are difficult to identify...
How much dilution will take place to support CEO salary of 450k plus 50% of that as a bonus ... before sales from approval of late stage 3 programs kick in? I sold half of my position today and will let the remainder lay dormant.
Yes, this used to be an extremely active board. Now, press releases, and cheerleaders Abundance and Ted O are not enough to keep people here.
Further research reveals that AXIM originally was a cannabinoid biotech then transitioned with the purchase of Sapphire Biotech (Doug Lake) to an oncology focused biotech. The October 2020 letter to shareholders (patent and EUA applications) appears to been have been nothing more than a scratch off lottery ticket. Might be time for another shareholder letter from John H. so we can decide whether we should buy this one or not!
In answer to my own question, it appears we have "purchased" the DED diagnostic technology kits (produced by the company in Spain) and revenue will come from CMS and other private insurance companies. Sapphire leases a 1900 sq.ft facility in San Diego and is doing the R&D in cancer research.
I have been adding shares for the past 18 months. From the website and other research, I found that AXIM is operating with a CEO (John H), Sapphire CEO (C Valencia) Senior VP (J Busby), a Board of Directors, and a Medical Advisory Board ..(all of which, I assume, have teaching/research responsibilities to other universities). Manufacturing appears to be a contracted 3rd party arrangement. I saw one reference to AXIM having "8 employees". Are these employees scientists/engineers with 6 figure salaries? Does AXIM own its lab or are we in leased facilities? Just trying to get a handle on how AXIM derives its revenue.
What's up with the high volume today.. the rights (NVACR) as well??
The lack of transparency with AXIM makes this a very difficult stock to own. If John H had quarterly earnings calls, progress on research of the compound SPX-1009, a realistic timeline for revenue to be derived from the DED program, etc. there would be no need for the widespread speculation found on this board.
Latest public ad from John H that I found.
Spot on Captain
No wonder we haven't heard from John H
Can anyone explain why the LAST letter to shareholder from CEO (John H) was dated Oct. 2020.
https://aximbiotech.com/axim-biotechnologies-issues-update-letter-to-shareholders-2020/
We shareholders deserve an updated progress report. i.e. oncology-focused research, the diagnostic testing of dry eye disease, and of course, how the company is handling the manufacturing aspect.
took a small position today. Kinda like playing 5 card stud and hanging around to get that last card.
further reason why big pharma has no interest in people using antibody testing at home
https://www.goodrx.com/conditions/covid-19/covid-pill-cost-availability?utm_medium=email&utm_source=bz&utm_campaign=20220120_c_newsletter_271
...maybe you can be a EUA sub at your daughters school....
this board has really gone dark...
Thanks for the link. This article is a little dated however. Dec 2020
Been adding shares for past 18 months. Needless to say it's #1 in my portfolio.
down to .19 pre split .. nasdaq didn't move it .. all of our PR firms haven't moved it .. can't hang on much longer without more dilution.
thanks Ezz for link to old video..I noticed (after watching that and the recent Nov 1 video).. Rob looks a whole lot healthier now ...he's learned some positive things in that regard .. hope it translates into positive things for the future of the company.
surely one of these days...one of these clinical trials...."even a blind squirrel eventually gets lucky"
added more today
out of the box everything works as advertised. easy to set up. I'm on my 4th day and working up to having it on 2-3 hours during the day. Used it under my pillow for 1st time last night. Stay tuned!
here is full link
just found this interview with CEO ... demand is there... supply chain issues to build the product. I have one .. been using it for 3 days.
$HAPBF
youtube.com/watch?v=c3vNvCb...
Long and strong....I hope you are right.
If there ever was a stock that is being manipulated, CYCA is it?
Up 20% on no volume? Can someone please explain that to me?
Is AXIM a one trick pony? What else is in the pipeline? I know about the recent eye addition. Everyone here sounds like they are holding their breath. What if we don't get EAU? Will life go on?
Keep an eye on this stock. I added some today. Earnings call transcript on Aug 31 lays out a roadmap that makes sense to me.
If they would only tell us who is buying their technology.
The business model and structure of this company is spot on.
Their conference call on Aug 16 explains both of these.
I'm with Randy here....show us the contracts, who has orders on the books, and update on sales staff.
"multi-billion dollar company" ...I've been here over a year and have come to believe .. "fish in the lake does not equal fish in the frying pan" AXIM must not be using the right bait.
my thoughts exactly ..I've been following for a year.
...is there any revenue coming in? ...orders? sales?
...hasn't seem to bother them for a couple years now
that's why I bailed @ .18 ...waiting to get back in.
thanks for info on this board. I rewatched the NewsMax interviews with Matt and don't know why I picked up shares in this company. It really isn't a Q&A interview, it's him taking the mike and spilling out a 2-3 minute memorized presentation. Took a loss but I'm totally out now. Good luck to all who are waiting till the end of the month.
I got out because of a lack of financials
.....and girls!!